September's Bloodbath History and 3 LEAPS Setups Worth Watching

Most traders treat September seasonality like a weather forecast — interesting trivia, nothing actionable. That's the wrong read. When a pattern repeats consistently enough to show up in 70+ years of market data, it stops being noise and starts being a setup. The real question isn't whether September will be rough. It's which stocks have the structural durability to survive a drawdown and still reward a well-positioned options trader on the other side. Because here's what most people miss: a seasonal selloff compresses equity prices while simultaneously expanding implied volatility — and that combination, if timed correctly, is exactly when deep out-of-the-money LEAPS calls on the right large-caps go from lottery tickets to calculated asymmetric bets.

What's Actually Happening

September's bad reputation isn't a myth. Since 1928, it's been the only month with a negative average return for the S&P 500 — down roughly 1.1% on average, with the losses clustering in years following strong summer rallies. Sound familiar? Markets have posted a meaningful run through mid-year, positioning is stretched long, and institutional players are returning from summer holidays with a mandate to rebalance and reduce risk. That mechanical selling pressure is real, and it hits growth and momentum names hardest.

But here's the structural nuance worth understanding: the stocks that hold up best during September drawdowns tend to share a specific profile — they have dominant market positions, recurring revenue streams, and balance sheets that function as shock absorbers. We're talking names like Johnson & Johnson (JNJ), Microsoft (MSFT), and Berkshire Hathaway (BRK.B). These aren't exciting tickers in a bull market. But when the tape turns ugly, they compress less, recover faster, and carry optionality that most traders never price correctly — especially 12 to 18 months out.

The macro backdrop adds another layer. With rate policy still in flux and earnings multiples sitting well above historical norms, any September catalyst — a hot inflation print, a Fed communication fumble, a geopolitical flare-up — could accelerate the seasonal pattern into something sharper than usual. That's not a bearish call. It's a calibration.

Why Options Traders Should Pay Attention

When equity markets sell off, implied volatility rises. That's not controversial. What is underappreciated is what happens to the options surface on large-cap, high-quality names during a controlled drawdown versus a panic event. On stocks like Microsoft (MSFT) or Visa (V), IV expansion during a moderate September pullback tends to be measured — not the explosive VIX spike you'd see in a flash crash. That means the options market gets just expensive enough to make near-term puts painful to buy, but doesn't completely reprice the far-dated call skew.

That gap matters. When a stock drops 8–12% during a seasonal selloff, the deep OTM LEAPS calls — the $0.03 to $0.07 strikes sitting 30–40% above current price — don't immediately reprice upward in lockstep with the equity decline. The market makers are focused on hedging the near-term move. Long-dated, far-OTM calls get temporarily mispriced as a result. And that's the window.

Consider a scenario: Microsoft (MSFT) trades at $420 in early September. A seasonal pullback pushes it to $385 by mid-month. A January 2027 $560 call that was priced at $0.06 before the selloff might now be priced at $0.04 — even though the fundamental bull case for MSFT over an 18-month horizon hasn't changed at all. You're getting longer duration and a lower strike relative to any recovery target, for less premium than before. That's not a coincidence. That's structure.

The same logic applies to names like Alphabet (GOOGL) and Amazon (AMZN), where the AI monetization story is still playing out over a multi-year arc. A September dip doesn't change the 2026 earnings trajectory. But it can meaningfully cheapen your entry on a LEAPS position that benefits from that trajectory.

The LEAPS Angle

The mechanics of a deep OTM LEAPS play during September are straightforward in theory and genuinely difficult in execution. You need three things to align: a stock with a credible 18–24 month catalyst, a price dislocation that creates a temporary mispricing on far-dated calls, and enough liquidity in the options chain to enter and exit without getting destroyed by the spread.

On the catalyst front, focus on names where secular growth drivers are intact regardless of what September does to price. Microsoft (MSFT) has Azure's growth trajectory and Copilot monetization beginning to show up in enterprise contracts. Visa (V) benefits from ongoing global cash-to-digital payment conversion — a multi-decade trend that a single quarter of consumer softness doesn't derail. Johnson & Johnson (JNJ) is mid-cycle on a pipeline reload following its consumer health spinoff, with several high-value oncology launches on the horizon.

For each of these, a realistic LEAPS scenario looks something like this: you buy a January 2027 call strike that's 35–40% OTM for $0.04–$0.07 per contract during a September dip. If the stock recovers and then appreciates meaningfully over 15–18 months, that premium can expand to $0.40–$1.20 — a 6x to 15x move on the option itself, even without the stock reaching the strike. That's the delta and vega working in your favor on the recovery leg.

Finding these setups manually is tedious — you're scanning hundreds of strikes across dozens of tickers, filtering for the right premium range, checking open interest, and timing the entry against the equity move. This is exactly the kind of workflow that tools like the StrikeEdge scanner are built for. Traders use it to surface deep OTM LEAPS calls in the $0.01–$0.08 range on large-caps, specifically flagging the setups where premium, liquidity, and catalyst timing converge. During a September selloff, that scanner becomes particularly relevant — the list of actionable setups tends to grow as prices drop and premiums compress.

The position sizing discipline matters as much as the stock selection. These are small-dollar, high-risk bets. Allocating 1–3% of a portfolio across 4–6 names is a reasonable framework. You're not betting the farm. You're buying optionality on a recovery you already believe in.

Key Risks to Watch

Let's be direct about what can go wrong. First, theta decay is relentless. Even on a January 2027 LEAPS, if the stock doesn't move meaningfully in the right direction within 6–9 months, your premium erodes. Deep OTM calls don't fight time well.

Second, IV crush works against you post-selloff. If you buy during peak September volatility and the market stabilizes quickly, implied volatility drops — and that can offset early delta gains. The entry point relative to the IV environment matters enormously.

Third, large-cap doesn't mean safe. Names like Alphabet (GOOGL) and Amazon (AMZN) can drop 25–30% in a real risk-off event. If September turns into something systemic rather than seasonal, your LEAPS entry point may simply be wrong, and the strikes you're holding become further OTM than projected.

Finally, liquidity in deep OTM LEAPS chains is often thin. Wide bid-ask spreads can mean you're paying a premium over fair value just to get in — and facing slippage on the way out.

September doesn't have to be a month you simply survive. Stocks with durable fundamentals and multi-year catalysts will likely be higher in January 2027 than they are during any September dip — that's the base case. The trade is positioning for that recovery before the market reprices it, using cheap LEAPS that September itself helped create. Identify the names, wait for the compression, size it correctly, and let time do the work. That's the edge.